SA Best Peanut Butter Business Plan — Investment Analysis
The project and equity returns, the DFI facility in the structure, and what the numbers do and do not support.
Investment Analysis
Jump to section
- Overview & contents
- i. Important Notice and Basis of Preparation
- 1. Executive Summary
- 2. Aflatoxin: The Question That Defines the Business
- 3. Market, Products and Pricing
- 4. Regulation and Food Safety
- 5. SWOT and Competitive Position
- 6. Operations
- 7. Financial Plan
- 8. Break-Even and Debt Service
- 9. Investment Analysis
- 10. Sensitivity and Scenario Analysis
- 11. Risk Analysis
- 12. Implementation Roadmap
- 13. Key Performance Indicators
- 14. Key Assumptions
- 15. Conclusion and Recommendation
- A. Appendix A: Consolidated Financial Summary
- B. Appendix B: Volume, Kernel and Cost Schedules
- C. Appendix C: Funding, Debt and Working Capital Schedules
- D. Appendix D: Risk Register
- E. Appendix E: Glossary
- 9.1 Returns
- 9.2 Sensitivity of the return to the exit assumption
- 9.3 What the return depends on
9.1 Returns
|
Measure |
Base case |
Comment |
|---|---|---|
|
Total funding requirement |
R74 120 000 |
Plus a R26 000 000 working capital facility |
|
Capital invested in the project |
R57 720 000 |
Capital expenditure plus non-working-capital pre-operational cost |
|
Promoter and investor equity |
R33 120 000 |
44.7% of the funding requirement |
|
Project internal rate of return |
15.5% |
Unlevered, five years plus a terminal value at 7.0x EBITDA |
|
Return to equity |
12.6% |
After debt service and facility movement |
|
Net present value at 12% |
R11 068 922 |
Positive |
|
Net present value at 15% |
R1 371 884 |
Marginal |
|
Net present value at 18% |
(R6 893 839) |
Negative |
|
Payback period |
8.8 years |
On unlevered project cash flow; well beyond the projection |
|
Terminal value |
R122 299 107 |
7.0x Year 5 EBITDA |
|
Cumulative project cash flow before terminal value |
(R51 125 699) |
The return is realised on the terminal position |
|
Assessed loss carried forward at Year 5 |
R17 519 710 |
A real shelter against Year 6 and Year 7 earnings, not valued here |
9.2 Sensitivity of the return to the exit assumption
|
Exit multiple of Year 5 EBITDA |
Terminal value (R) |
Project IRR |
Equity IRR |
|---|---|---|---|
|
5.0x |
87 356 505 |
8.9% |
-0.2% |
|
6.0x |
104 827 806 |
12.4% |
6.9% |
|
7.0x |
122 299 107 |
15.5% |
12.6% |
|
8.0x |
139 770 408 |
18.3% |
17.4% |
|
9.0x |
157 241 709 |
20.8% |
21.5% |
The base case applies seven times Year 5 EBITDA, which is consistent with branded food assets in a defensive category. At five times the project returns 11.6 per cent; at nine times it returns 18.5 per cent. The multiple is doing a great deal of work here, and what it is really pricing is the durability of the own-brand shelf position and the credibility of the food safety record. A manufacturer with five years of clean release data in a category that has recalled twice in two years is worth a materially different multiple from one without it.
9.3 What the return depends on
|
Lever |
Effect on Year 5 EBITDA |
Assessment |
|---|---|---|
|
Selling prices 8% higher |
+R12 401 200 |
The largest lever, and largely a function of mix and listing quality |
|
Kernel price 12% lower |
+R8 810 700 |
Outside the plant’s control; a groundnut rebate would deliver it |
|
Volume 15% higher |
+R6 028 484 |
Capacity exists on two shifts; the constraint is listings, not plant |
|
Own-brand mix 10 points higher |
+R2 691 800 |
The most controllable lever, and the one the plan is built around |
|
Intake rejection 3 points lower |
+R2 220 950 |
Supplier qualification. Rejecting bad kernels is expensive; buying from suppliers who send them is worse |
|
Conversion cost 12% lower |
+R1 739 350 |
The weakest lever, and R890 a tonne of it is testing that must not be cut |
Two observations follow. The largest levers — price and kernel cost — are the two the plant least controls, which is the signature of a spread business. And the most controllable lever, own-brand mix, is worth R5 454 550 across the range tested, which is why the sales function and the listing budget are funded from launch rather than deferred until the plant is running.